Genomic loss of heterozygosity and survival in the REAL3 trial

Smyth, E.C., Cafferkey, C., Loehr, A. et al. (17 more authors) (2018) Genomic loss of heterozygosity and survival in the REAL3 trial. Oncotarget, 9 (94). pp. 36654-36665. ISSN 1949-2553

Abstract

Metadata

Authors/Creators:
  • Smyth, E.C.
  • Cafferkey, C.
  • Loehr, A.
  • Waddell, T.
  • Begum, R.
  • Peckitt, C.
  • Harding, T.C.
  • Nguyen, M.
  • Okines, A.F.
  • Raponi, M.
  • Rao, S.
  • Watkins, D.
  • Starling, N.
  • Middleton, G.W.
  • Wadsley, J.
  • Mansoor, W.
  • Crosby, T.
  • Wotherspoon, A.
  • Chau, I.
  • Cunningham, D.
Copyright, Publisher and Additional Information: © 2018 Smyth et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. (http://creativecommons.org/licenses/by/3.0/)
Keywords: gastric cancer; oesophageal cancer; chemotherapy; homologous recombination deficiency; loss of heterozygosity
Dates:
  • Accepted: 6 October 2018
  • Published (online): 30 November 2018
  • Published: 30 November 2018
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Sheffield Teaching Hospitals
Depositing User: Symplectic Sheffield
Date Deposited: 30 Nov 2020 11:58
Last Modified: 30 Nov 2020 11:58
Status: Published
Publisher: Impact Journals, LLC
Refereed: Yes
Identification Number: https://doi.org/10.18632/oncotarget.26336
Related URLs:

Export

Statistics